| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $519.1M | $924.3M | $679.0M |
| YoY Revenue Growth % | -43.8% | +36.1% | — |
| Gross Profit | $45.2M | $29.6M | — |
| Gross Margin % | 8.7% | 3.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$423.2M | -$786.3M | -$735.9M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$464.2M | -$1.10B | -$742.0M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$333.9M | -$848.5M | -$386.9M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$333.9M | -$848.5M | -$386.9M |
| FCF Margin % | -64.3% | -80.0% | -57.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $73.4M | $103.1M | — |
| Total Debt (Short + Long Term) | $128.9M | $103.0M | — |
| Total Stockholders' Equity | -$1.32B | -$852.9M | — |